- Home
- COEP vs RDI Comparison
COEP vs RDI Comparison
Compare COEP & RDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COEP
- RDI
- Stock Information
- Founded
- COEP 2017
- RDI 1937
- Country
- COEP United States
- RDI United States
- Employees
- COEP N/A
- RDI N/A
- Industry
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- RDI Movies/Entertainment
- Sector
- COEP Health Care
- RDI Consumer Discretionary
- Exchange
- COEP Nasdaq
- RDI Nasdaq
- Market Cap
- COEP 27.4M
- RDI 30.6M
- IPO Year
- COEP N/A
- RDI N/A
- Fundamental
- Price
- COEP $8.28
- RDI $1.28
- Analyst Decision
- COEP
- RDI Hold
- Analyst Count
- COEP 0
- RDI 1
- Target Price
- COEP N/A
- RDI $2.40
- AVG Volume (30 Days)
- COEP 33.0K
- RDI 30.6K
- Earning Date
- COEP 08-15-2025
- RDI 08-13-2025
- Dividend Yield
- COEP N/A
- RDI N/A
- EPS Growth
- COEP N/A
- RDI N/A
- EPS
- COEP N/A
- RDI N/A
- Revenue
- COEP $62,874.00
- RDI $205,644,000.00
- Revenue This Year
- COEP N/A
- RDI $7.47
- Revenue Next Year
- COEP N/A
- RDI $13.22
- P/E Ratio
- COEP N/A
- RDI N/A
- Revenue Growth
- COEP N/A
- RDI N/A
- 52 Week Low
- COEP $2.31
- RDI $1.17
- 52 Week High
- COEP $13.70
- RDI $1.89
- Technical
- Relative Strength Index (RSI)
- COEP 50.63
- RDI 44.08
- Support Level
- COEP $7.25
- RDI $1.21
- Resistance Level
- COEP $8.86
- RDI $1.37
- Average True Range (ATR)
- COEP 0.60
- RDI 0.06
- MACD
- COEP 0.06
- RDI -0.01
- Stochastic Oscillator
- COEP 71.77
- RDI 35.00
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
About RDI Reading International Inc
Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial and live theater assets.